Mehmet Yildiz is a Cardiology physician affiliated with Christ Hospital. OpenAlex indexes 27 publications with 546 citations (h-index 8); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2123 Auburn Ave Ste 320
Cincinnati, OH 452192906
Telephone
513-206-1120Provider last certified this registry record 4 May 2026.
Clinical trials
- Periodontal Effects of Orthodontic Mini-Screws
Sponsor: Dr. Mehmet Selim Yildiz
- Evaluation of Peri-implant Conditions of Orthodontic Mini Implants
Sponsor: Dr. Mehmet Selim Yildiz
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Biosense Webster, Inc.Program year20255 payments
- AtriCure, Inc.Program year20251 payment
- Abbott LaboratoriesProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
65.5%Statin14.1%Atorvastatin Calcium52%Rosuvastatin Calcium48%Part D<11 patientsPCSK9 Inhibitor14.1%Repatha Sureclick100%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
21.5%SGLT2 inhibitor14.7%Jardiance100%Part D≥13 patientsProton pump inhibitor6.8%Pantoprazole Sodium100%Part D<11 patientsBlood & clotting
13%Factor Xa inhibitor6.8%Eliquis100%Part D<11 patientsP2Y12 inhibitor6.2%Clopidogrel100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Sex Differences in Patients Presenting With ST‐Segment Elevation Myocardial Infarction and Nonobstructive Coronary Arteries
Catheterization and Cardiovascular Interventions
2025 - DOUBLE JEOPARDY: CONCOMITANT TRANSTHYRETIN CARDIAC AMYLOIDOSIS AND SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY TREATED WITH MAVACAMTEN
Journal of the American College of Cardiology
2025 - In-hospital cardiac arrest after STEMI: prevention strategies and post-arrest care
Expert Review of Cardiovascular Therapy
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Emerson Perin, MD
Christ Hospital
Mickey Karram, MD
Christ Hospital
Odayme Quesada, MD
Christ Hospital
Michael Cardi, MD
Christ Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”